Zuber Lawler Earns a Top-5 Spot in Law360’s 2025 Diversity Snapshot Survey
December 2, 2025 | Press
Zuber Lawler has once again earned a top-5 spot in Law360’s 2025 Diversity Snapshot, ranking among the leading U.S. law firms for partner and associate diversity within firms of 100 or fewer attorneys. This marks the firm’s fifth consecutive year achieving a top-5 diversity ranking in its size category.
Diversity is integral to Zuber Lawler’s identity, strengthening the firm’s ability to deliver nuanced, high-quality counsel across complex and emerging industries. The firm believes that a broad range of perspectives enhances problem-solving, drives better outcomes for clients, and enriches its internal culture.
“We are pleased that Zuber Lawler was ranked in the top-5 in the Diversity Snapshot Survey of law firms of less than 100 attorneys for the fifth year in a row,” stated Eileen Letts, the Chicago-based Chief Administrative Partner of the firm. “Our firm takes pride in its diverse workforce. We understand that diverse perspectives help us to make better decisions and to do better work.”
Ms. Letts sits on the Board of Directors of the National Association of Minority and Women-Owned Law Firms (NAMWOLF). Ms. Letts also co-authored the acclaimed book “Left Out and Left Behind,” organized by the Long-Term Careers for Women in Law Initiative and published by the American Bar Association.”
Disclaimer: This content may be an attorney advertisement. The information provided on this page does not constitute legal advice. All information, content, and materials available in this post are for general informational purposes only, and might not be up to date. The content on this website is provided “as is,” and no representations are made that the content is free of error. Usage of this website or any resources contained within it does not create an attorney-client relationship between user and any author of relevant content (or any law firm or company of which the author might be a part). Readers of this content should contact their attorney to obtain advice with respect to any particular legal matter. Any and all liability with respect to actions taken or not taken based on the contents of this website are hereby expressly disclaimed.
Recent Updates
An FDA Panel Just Voted to Widen Access to Peptides. Here’s What It Actually Means for the Longevity Space July 30, 2026
Generative AI Legal Issues: 5 Critical Questions Every Business Must Answer Before Deploying AI Solutions May 21, 2026
Medical Rescheduling, Recreational Risk: How Schedule III Could Reshape Adult-Use Cannabis February 18, 2026
Schedule III Cannabis: FDA’s New Frontier January 27, 2026
Data Privacy and AI in Longevity: Legal Risks Around Predictive Biomarkers and Health Data January 23, 2026
2026 Employment Law Developments: Key Takeaways for Employers December 22, 2025